Trademark: 78946349
Word
SWANZA
Status
Dead
Status Code
606
Status Date
Thursday, June 5, 2008
Serial Number
78946349
Mark Type
4000
Filing Date
Monday, August 7, 2006
Published for Opposition
Tuesday, September 11, 2007
Abandoned Date
Thursday, June 5, 2008

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; syringes filled with a pharmaceutical product for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Trademark Events
Aug 13, 2008
Abandonment Notice Mailed - No Use Statement Filed
Aug 12, 2008
Abandonment - No Use Statement Filed
Dec 4, 2007
Noa Mailed - Sou Required From Applicant
Sep 11, 2007
Published For Opposition
Aug 22, 2007
Notice Of Publication
Aug 3, 2007
Law Office Publication Review Completed
Aug 3, 2007
Assigned To Lie
Jun 20, 2007
Approved For Pub - Principal Register
Jun 19, 2007
Teas/Email Correspondence Entered
Jun 19, 2007
Correspondence Received In Law Office
Jun 19, 2007
Teas Response To Office Action Received
Jan 3, 2007
Non-Final Action Mailed
Dec 31, 2006
Non-Final Action Written
Dec 30, 2006
Assigned To Examiner
Dec 30, 2006
Assigned To Examiner
Aug 10, 2006
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24